Quantinuum (NASDAQ:QNT) Given New $80.00 Price Target at JPMorgan Chase & Co.

Quantinuum (NASDAQ:QNT) had its price objective decreased by JPMorgan Chase & Co. from $97.00 to $80.00 in a research note published on Friday morning,Benzinga reports. JPMorgan Chase & Co. currently has an overweight rating on the stock.

A number of other research analysts have also recently weighed in on QNT. Sanford C. Bernstein reaffirmed a “hold” rating on shares of Quantinuum in a report on Wednesday, August 12th. Rosenblatt Securities reissued a “buy” rating and set a $155.00 target price on shares of Quantinuum in a research note on Thursday, October 22nd. Weiss Ratings assumed coverage on Quantinuum in a research report on Monday, August 31st. They set a “sell (d)” rating on the stock. Cantor Fitzgerald cut their price target on Quantinuum from $90.00 to $55.00 and set an “overweight” rating for the company in a research note on Friday. Finally, Morgan Stanley raised Quantinuum from an “equal weight” rating to an “overweight” rating and reduced their price target for the stock from $78.00 to $62.00 in a report on Thursday, October 15th. Thirteen research analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $85.62.

Quantinuum Stock Performance

Shares of NASDAQ:QNT traded up $7.75 during trading on Friday, hitting $37.57. 5,036,156 shares of the stock traded hands, compared to its average volume of 2,182,406. The stock has a market capitalization of $9.89 billion and a P/E ratio of -134.18. The business’s fifty day simple moving average is $43.41. Quantinuum has a 52-week low of $28.31 and a 52-week high of $86.79.

Quantinuum (NASDAQ:QNT) last announced its quarterly earnings results on Thursday, November 5th. The company reported ($0.29) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.99) by $0.70. The firm had revenue of $9.05 million for the quarter. As a group, equities research analysts anticipate that Quantinuum will post -4.76 EPS for the current fiscal year.

Institutional Investors Weigh In On Quantinuum

Institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Russell Investments Group Ltd. purchased a new position in Quantinuum during the third quarter valued at $97,000. Pier 88 Investment Partners LLC purchased a new stake in shares of Quantinuum during the third quarter worth about $154,000. Fifth Third Bancorp raised its position in shares of Quantinuum by 1,530.2% during the 3rd quarter. Fifth Third Bancorp now owns 1,027 shares of the company’s stock worth $49,000 after purchasing an additional 964 shares during the last quarter. State of Wyoming acquired a new position in shares of Quantinuum during the 3rd quarter worth about $378,000. Finally, Flagship Harbor Advisors LLC purchased a new position in Quantinuum in the 3rd quarter valued at about $206,000.

Trending Headlines about Quantinuum

Here are the key news stories impacting Quantinuum this week:

• Positive Sentiment: Quantinuum beat third-quarter expectations, reporting a loss of $0.29 per share versus the $0.99 loss analysts expected. Revenue rose 233% year over year to $9.05 million, and the company raised its full-year 2026 revenue outlook. The report also noted that gross margin turned positive, although expenses are increasing. Quantinuum Q3 results and outlook
• Positive Sentiment: Commercial traction strengthened: Quantinuum said it secured its largest cloud agreement to date, expanded access through a hyperscaler and an Oracle beta launch, and saw platform adoption rise nearly 20% quarter over quarter. These developments could help build future revenue. Quantinuum Q3 results and outlook
• Positive Sentiment: The company outlined its Nexus developer-platform roadmap, connecting application development with future hardware, including its planned Apollo fault-tolerant quantum computer. The roadmap and reported technical milestones could strengthen Quantinuum’s longer-term competitive position. Nexus roadmap announcement
• Negative Sentiment: Some analysts lowered their forecasts and price targets after the results. Cantor Fitzgerald cut its target from $90 to $55 and Needham lowered its target from $100 to $60, though both retained positive ratings—Overweight and Buy, respectively. The cuts may temper enthusiasm despite the earnings beat. Analysts cut forecasts after Q3 results

About Quantinuum

Quantinuum is a quantum computing company formed in 2021 through the combination of Honeywell Quantum Solutions and Cambridge Quantum. The company develops full-stack quantum computing technologies designed to support research and commercial applications across industries, including chemistry, materials science, cybersecurity, finance and artificial intelligence.

Its offerings include trapped-ion quantum computers, quantum software and development tools. Quantinuum’s software portfolio includes the TKET quantum compiler, InQuanto quantum chemistry platform, Quantum Origin quantum-enhanced cybersecurity solutions and the Nexus platform for developing and managing quantum applications.